|
|
40
|
|
|
A321S
|
|
|
VENLAFAXINE SR 37.5MG CAP (CIP/AHI)
|
|
|
VENLAFAXINE
|
|
|
VENLAFAXINE SR
|
|
|
100'S
|
|
|
BP
|
|
|
35.20
|
|
|
0.35
|
|
|
37.5MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
CIP
|
|
|
CIPLA LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
100
|
|
|
No
|
|
|
28160416
|
|
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|